Retraction
Polymorphisms of tumor necrosis factor-α, interleukin-10, cytochrome P450 3A5 and ABCB1 in Chinese liver transplant patients treated with immunosuppressant tacrolimus
Paper Information
Record ID:
55618
Author(s):
Publication Date:
May 24, 2007
Retraction Date:
August 10, 2024
(1.3 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Elsevier
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (39)
39
Total Citations2
Post-Retraction(5.1%)
37
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
38
Days since retraction (latest)
Interleukin 6 and interleukin 17A serum levels and gene- polymorphisms in the development of early allograft rejection in living donor liver transplant recipients
Samah Awad, Eman Helmy El Batanony, Shaimaa K Elmahdy et al. (8 authors)
Scientific Reports
Open Access
Published: Sep 2024
38 days after retraction
Pharmacogenetic analysis of interleukin-10 variants and tacrolimus metabolism in kidney transplant patients from Pakistani population
Tuba Batool, F. Ali Jamaleddin Ahmad, Rasheeda Bashir et al. (4 authors)
Molecular Biology Reports
Published: Aug 2024
21 days after retraction
Impact of IL-6 and IL-10 genotypes on tacrolimus dose requirements in kidney transplant recipients: Monte Carlo analysis
Nikola Stefanović, Katarina Danković, Tatjana Cvetković et al. (8 authors)
Pharmacogenomics
Published: May 2024
100 days before retraction
Impact of single-nucleotide polymorphisms on tacrolimus pharmacokinetics in liver transplant patients after switching to once-daily dosing
Jangho Park, Kwang‐Woong Lee, Seung Cheol Oh et al. (10 authors)
Hepatology International
Published: Aug 2022
3 citations
3 citations
725 days before retraction
Impact of genetic polymorphisms at the promoter area of IL-10 gene on tacrolimus level in Jordanian renal transplantation recipients
Bara'ah Khaleel, Al‐Motassem Yousef, Mazhar Salim Al Zoubi et al. (8 authors)
Journal of Medical Biochemistry
Open Access
Published: Dec 2021
5 citations
5 citations
967 days before retraction
The impact of IL-10 and CYP3A5 gene polymorphisms on dose-adjusted trough blood tacrolimus concentrations in early post-renal transplant recipients
Zhaolin Chen, Xi Cheng, Liwen Zhang et al. (8 authors)
Pharmacological Reports
Published: Jun 2021
6 citations
6 citations
1162 days before retraction
Influence of ABCB1 gene polymorphism on concentration to dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients
Fahad Azam, Moosa Khan, Tanwir Khaliq et al. (4 authors)
Pakistan Journal of Medical Sciences
Open Access
Published: Feb 2021
12 citations
12 citations
1262 days before retraction
The effect of genetic variations for interleukin-10 (IL-10) on the efficacy of immunosuppressive therapy in patients after kidney transplantation
Anna Bogacz, Anna Polaszewska, Joanna Bartkowiak-Wieczorek et al. (12 authors)
International Immunopharmacology
Published: Oct 2020
9 citations
9 citations
1402 days before retraction
Clinical significance of personalized tacrolimus dosing by adjusting to donor CYP3A‐status in liver transplant recipients
Nóra Csikány, Ádám Ferenc Kiss, Máté Déri et al. (12 authors)
British Journal of Clinical Pharmacology
Open Access
Published: Sep 2020
9 citations
9 citations
1412 days before retraction
Impact of body composition on pharmacokinetics of tacrolimus in liver transplantation recipients
Lu Chen, Xiaoqing Lu, Guijun Tan et al. (6 authors)
Xenobiotica
Published: Apr 2019
8 citations
8 citations
1941 days before retraction
Enhanced responsiveness of platelets to vicagrel in IL‐10‐deficient mice through STAT3‐dependent up‐regulation of the hydrolase arylacetamide deacetylase in the intestine
Yumeng Jia, Huan Zhou, Ting Tai et al. (10 authors)
British Journal of Pharmacology
Open Access
Published: Mar 2019
10 citations
10 citations
1988 days before retraction
Effect of <scp>CYP</scp>3A5*1 expression on tacrolimus required dose after liver transplantation: A systematic review and meta‐analysis
Fatemeh Hendijani, Negar Azarpira, Maryam Kaviani
Clinical Transplantation
Published: Jun 2018
15 citations
15 citations
2262 days before retraction
Effects of <i>UGT1A1, CYP3A5</i> and <i>ABCB1</i> Genetic Variants on Pharmacokinetics of Antihistamine Drug Mizolastine in Chinese Healthy Volunteers
Pu Li, Min‐Ji Wei, Zhiyuan Zhang et al. (11 authors)
Basic & Clinical Pharmacology & Toxicology
Open Access
Published: Apr 2018
1 citation
1 citation
2297 days before retraction
Attempted Validation of 44 Reported SNPs Associated with Tacrolimus Troughs in a Cohort of Kidney Allograft Recipients
William S. Oetting, Baolin Wu, David P. Schladt et al. (10 authors)
Pharmacogenomics
Open Access
Published: Jan 2018
27 citations
27 citations
2404 days before retraction
Effects of functional CYP2C8,CYP2C9,CYP3A5,and ABCB1 genetic variants on the pharmacokinetics of insulin sensitizer pioglitazone in Chinese Han individuals
Shengju Yin, Huimin Qi, Xin Wang et al. (11 authors)
Pharmacogenetics and Genomics
Published: Jan 2017
4 citations
4 citations
2761 days before retraction
Influence of IL-18 and IL-10 Polymorphisms on Tacrolimus Elimination in Chinese Lung Transplant Patients
Xiaoqing Zhang, Jiandong Xu, Junwei Fan et al. (11 authors)
Disease Markers
Open Access
Published: Jan 2017
12 citations
12 citations
2778 days before retraction
Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation
Hiroyuki Kato, Masanobu Usui, Yuichi Muraki et al. (13 authors)
Transplantation Proceedings
Published: May 2016
10 citations
10 citations
3023 days before retraction
Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients
Dirk Jan A. R. Moes, Sebastiaan A. S. van der Bent, Jesse J. Swen et al. (10 authors)
European Journal of Clinical Pharmacology
Open Access
Published: Oct 2015
52 citations
52 citations
3206 days before retraction
Impact of Genetic Polymorphisms of ABCB1 (MDR1, P-Glycoprotein) on Drug Disposition and Potential Clinical Implications: Update of the Literature
Stefan Wolking, Elke Schaeffeler, Holger Lerche et al. (5 authors)
Clinical Pharmacokinetics
Published: Apr 2015
278 citations
278 citations
3411 days before retraction
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for <i>CYP3A5</i> Genotype and Tacrolimus Dosing
Kelly A. Birdwell, Brian S. Decker, JM Barbarino et al. (16 authors)
Clinical Pharmacology & Therapeutics
Open Access
Published: Mar 2015
597 citations
597 citations
3433 days before retraction
Tacrolimus in preventing transplant rejection in&nbsp;Chinese patients &ndash; optimizing use
Liang Li, Chuanjiang Li
Drug Design Development and Therapy
Open Access
Published: Jan 2015
30 citations
30 citations
3509 days before retraction
Association of <scp>TNF</scp>‐α, <scp>TGF</scp>‐β1, <scp>IL</scp>‐10, <scp>IL</scp>‐6, and <scp>IFN</scp>‐γ gene polymorphism with acute rejection and infection in lung transplant recipients
Hui‐Jun Mu, Ping Xie, Jingyu Chen et al. (7 authors)
Clinical Transplantation
Published: Jun 2014
18 citations
18 citations
3698 days before retraction
Maternal Medication Use, Fetal 3435 C>T Polymorphism of the ABCB1 Gene, and Risk of Isolated Septal Defects in a Han Chinese Population
Chuan Wang, Kaiyu Zhou, Liang Xie et al. (9 authors)
Pediatric Cardiology
Published: Apr 2014
7 citations
7 citations
3769 days before retraction
Association of Hemoglobin Levels, CYP3A5, and NR1I3 Gene Polymorphisms with Tacrolimus Pharmacokinetics in Liver Transplant Patients
Dawei Chen, Feng Guo, Jinxiu Shi et al. (7 authors)
Drug Metabolism and Pharmacokinetics
Published: Dec 2013
27 citations
27 citations
3890 days before retraction
The effect of ABCB1 C3435T polymorphism on pharmacokinetics of tacrolimus in liver transplantation: A meta-analysis
Yuan-Yuan Liu, Changping Li, Zhuang Cui et al. (8 authors)
Gene
Published: Sep 2013
14 citations
14 citations
3984 days before retraction
Novel Single Nucleotide Polymorphisms in Interleukin 6 Affect Tacrolimus Metabolism in Liver Transplant Patients
Dawei Chen, Junwei Fan, Feng Guo et al. (6 authors)
PLoS ONE
Open Access
Published: Aug 2013
20 citations
20 citations
4002 days before retraction
PharmGKB summary
Julia M. Barbarino, Christine E. Staatz, Raman Venkataramanan et al. (5 authors)
Pharmacogenetics and Genomics
Open Access
Published: Aug 2013
221 citations
221 citations
4022 days before retraction
PharmGKB summary
Julia M. Barbarino, Christine E. Staatz, Raman Venkataramanan et al. (5 authors)
Europe PMC (PubMed Central)
Open Access
Published: Aug 2013
2 citations
2 citations
4022 days before retraction
From gut to kidney: Transporting and metabolizing calcineurin-inhibitors in solid organ transplantation
Noël Knops, Elena Levtchenko, Bert van den Heuvel et al. (4 authors)
International Journal of Pharmaceutics
Published: May 2013
74 citations
74 citations
4096 days before retraction
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients
Alessio Provenzani, Andrew D. Santeusanio, Erin Mathis et al. (11 authors)
World Journal of Gastroenterology
Open Access
Published: Jan 2013
89 citations
89 citations
4239 days before retraction
Interleukin-10-1082G/A polymorphism and acute liver graft rejection: A meta-analysis
Fei Liu
World Journal of Gastroenterology
Open Access
Published: Jan 2012
16 citations
16 citations
4605 days before retraction
The associations of IL-18 serum levels and promoter polymorphism with tacrolimus pharmacokinetics and hepatic allograft dysfunction in Chinese liver transplantation recipients
Yi Li, Yuangao Zou, Bei Cai et al. (7 authors)
Gene
Published: Oct 2011
13 citations
13 citations
4683 days before retraction
Impact of interleukin-10 gene polymorphisms on tacrolimus dosing requirements in Chinese liver transplant patients during the early posttransplantation period
Xiaoqing Zhang, Zhaowen Wang, Junwei Fan et al. (5 authors)
European Journal of Clinical Pharmacology
Published: Feb 2011
38 citations
38 citations
4915 days before retraction
Association of IL-6 promoter and IFN-γ gene polymorphisms with acute rejection of liver transplantation
Mohammad Hossein Karimi, Saeed Daneshmandi, Ali Akbar Pourfathollah et al. (8 authors)
Molecular Biology Reports
Published: Dec 2010
36 citations
36 citations
4999 days before retraction
Tumor necrosis factor-alpha-308 G/A polymorphism and acute liver graft rejection: A meta-analysis
Fei Liu, Bo Li, Yonggang Wei et al. (6 authors)
Transplant Immunology
Published: Oct 2010
3 citations
3 citations
5062 days before retraction
Impact of ATP-binding cassette, subfamily B, member 1 pharmacogenetics on tacrolimus-associated nephrotoxicity and dosage requirements in paediatric patients with liver transplant
Ahmed F. Hawwa, James C. McElnay
Expert Opinion on Drug Safety
Published: Jul 2010
15 citations
15 citations
5140 days before retraction
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part II
Christine E. Staatz, Lucy Goodman, Susan E. Tett
Clinical Pharmacokinetics
Published: Mar 2010
340 citations
340 citations
5267 days before retraction
Effect of CYP3A and ABCB1 Single Nucleotide Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Calcineurin Inhibitors: Part I
Christine E. Staatz, Lucy Goodman, Susan E. Tett
Clinical Pharmacokinetics
Published: Feb 2010
319 citations
319 citations
5282 days before retraction
Population pharmacokinetics of tacrolimus and CYP3A5, MDR1 and IL-10 polymorphisms in adult liver transplant patients
Dong Ming Li, Wan-Liang Lü, J.-Y. Zhu et al. (6 authors)
Journal of Clinical Pharmacy and Therapeutics
Open Access
Published: Sep 2007
72 citations
72 citations
6175 days before retraction
Quick Stats
Total Citations:
39
Years Since Retraction:
1.3 year
Open Access:
Yes
Last Checked:
Jul 24, 2025